Clinical Trial Update: Pharmacokinetics of Posaconazole (Noxafil®) as Prophylaxis for Invasive Fungal Infections [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update reporting pharmacokinetics of posaconazole (Noxafil) when used as prophylaxis for invasive fungal infections in patients undergoin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Allogeneic Stem Cell Transplantation
• Graft-versus-host Disease
• Myelodysplastic Syndrome

Drugs mentioned

• NOXAFIL (POSACONAZOLE)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Allogeneic Stem Cell Transplant, Acute Graft Versus Host Disease | Phase 4 | Status: COMPLETED